# Neurohope Therapeutics, Inc.

Canonical: https://abierto.us/vendors/neurohope-therapeutics-inc-yh1jee27me68

- UEI: YH1JEE27ME68
- CAGE: 03W69
- Location: Greenville, SC
- Awards in window: 2 (4 transactions), $1,535,766 obligated, January 31, 2025 to May 26, 2026

## Awarding agencies

- Defense Health Agency: 2 awards, $1,535,766

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $1,535,766

## Competition

- Full and Open Competition After Exclusion of Sources: 2 awards

## Largest awards

- HT942726CE012 (definitive contract): $1,286,279, Defense Health Agency. Dexamethasone Nanotherapeutics for Traumatic Brain Injury. https://www.usaspending.gov/award/CONT_AWD_HT942726CE012_9700_-NONE-_-NONE-/
- HT942525P0023 (purchase order): $249,487, Army Med Res Acq Activity. DHA SBIR Phase I for Project Titled, "dexamethasone Nanotherapeutics for Traumatic Brain Injury". https://www.usaspending.gov/award/CONT_AWD_HT942525P0023_9700_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/neurohope-therapeutics-inc-yh1jee27me68.